PANoptosis in microbial infection

•Cells exposed to TLR ligands and cytokines during infection activate PANoptosis.•RIPK1-dependent PANoptosome is formed when cell survival signaling is inhibited.•Influenza A virus Z-RNAs bind and activate ZBP1, promoting PANoptosome formation. The immune system has evolved multiple mechanisms to re...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in microbiology Vol. 59; pp. 42 - 49
Main Authors Place, David E, Lee, SangJoon, Kanneganti, Thirumala-Devi
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2021
Subjects
Online AccessGet full text
ISSN1369-5274
1879-0364
1879-0364
DOI10.1016/j.mib.2020.07.012

Cover

More Information
Summary:•Cells exposed to TLR ligands and cytokines during infection activate PANoptosis.•RIPK1-dependent PANoptosome is formed when cell survival signaling is inhibited.•Influenza A virus Z-RNAs bind and activate ZBP1, promoting PANoptosome formation. The immune system has evolved multiple mechanisms to restrict microbial infections and regulate inflammatory responses. Without appropriate regulation, infection-induced inflammatory pathology can be deadly. The innate immune system recognizes the microbial molecules conserved in many pathogens and engages a rapid response by producing inflammatory mediators and activating programmed cell death pathways, including pyroptosis, apoptosis, and necroptosis. Activation of pattern recognition receptors, in combination with inflammatory cytokine-induced signaling through death domain-containing receptors, initiates a highly interconnected cell death process called PANoptosis (pyroptosis, apoptosis, necroptosis). Broadly speaking, PANoptosis is critical for restricting a wide range of pathogens (including bacteria, viruses, fungi, and parasites), which we describe in this review. We propose that re-examining the role of cell death and inflammatory cytokines through the lens of PANoptosis will advance our understanding of host–pathogen evolution and may reveal new treatment strategies for controlling a wide range of infectious diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1369-5274
1879-0364
1879-0364
DOI:10.1016/j.mib.2020.07.012